Valuation: Illumina, Inc.

Market Cap 32.2B 29.02B 26.81B 24.24B 45.85B 3,020B 46.98B 321B 128B 1,617B 121B 118B 5,146B P/E 2026 *
42.1x
P/E 2027 * 35.8x
Enterprise Value 32.11B 28.94B 26.74B 24.17B 45.73B 3,012B 46.86B 320B 128B 1,613B 121B 118B 5,133B EV / Sales 2026 *
6.94x
EV / Sales 2027 * 6.27x
Free-Float
74.99%
Yield 2026 *
-
Yield 2027 * -
1 day-0.92%
1 week-6.01%
Current month-9.77%
1 month-23.45%
3 months+10.42%
6 months+49.41%
Current year+62.34%
1 week 205.51
Extreme 205.51
227.71
1 month 205
Extreme 205
294.2
Current year 112.65
Extreme 112.65
309.34
1 year 112.65
Extreme 112.65
309.34
3 years 68.7
Extreme 68.7
309.34
5 years 68.7
Extreme 68.7
428
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 25/09/2023
Director of Finance/CFO 50 15/04/2024
Chief Tech/Sci/R&D Officer 55 29/05/2025
Director TitleAgeSince
Director/Board Member 65 28/07/2016
Director/Board Member 66 01/01/2017
Director/Board Member 65 05/02/2019
Date Insider Type Main position Quantity % Market Cap. Importance
4/11/26
Corvex Management LP
SellCompany -50,000 0.0331%
3/11/26 Other

Director

0 0.0000%
5/10/26 Tax

Chief Executive Officer

-1,303 0.0009%
Change 5-day change 1-year change 3-year change Capi.($)
-0.92%-6.01%+73.68%+116.46% 32.2B
-0.07%+1.64%+22.37%+60.05% 266B
-0.34%+0.16%+9.05%+19.45% 166B
-0.11%-6.76%-21.43%+62.00% 156B
+0.96%-1.51%-55.97%-12.47% 65.41B
+1.73%+6.48%+24.25%+64.79% 60.84B
+0.45%-2.84%-2.45%-7.80% 53.75B
-0.52%-0.12%+18.42%+63.13% 49.89B
-0.26%-1.89%+1.90%+84.62% 49.34B
-0.97%+0.71%+21.95%+84.00% 46.28B
Average -0.01%-0.75%+9.18%+53.42% 95B
Weighted average by Cap. -0.03%-0.58%+6.55%+49.22%

Financials

2026 *2027 *
Net sales 4.63B 4.17B 3.86B 3.49B 6.59B 434B 6.76B 46.21B 18.42B 233B 17.38B 17.01B 740B 4.96B 4.47B 4.13B 3.73B 7.06B 465B 7.24B 49.49B 19.72B 249B 18.61B 18.22B 793B
Net income 792M 714M 659M 596M 1.13B 74.28B 1.16B 7.9B 3.15B 39.78B 2.97B 2.91B 127B 914M 824M 761M 688M 1.3B 85.74B 1.33B 9.12B 3.64B 45.92B 3.43B 3.36B 146B
Net Debt -83.57M -75.32M -69.58M -62.91M -119M -7.84B -122M -834M -332M -4.2B -314M -307M -13.36B -1.1B -994M -918M -830M -1.57B -103B -1.61B -11.01B -4.39B -55.4B -4.14B -4.05B -176B
Projected Income Statement - Annual - Illumina, Inc.
Logo Illumina, Inc.
Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and biotechnology companies. Net sales break down by source of income as follows: - product sales (85.4%): tools and instruments for sequencing, genotyping, genetic expression, etc.; - sales of services (14.6%). Net sales are distributed geographically as follows: the United States (51.6%), Americas (3.8%), Europe (29.1%), Asia/Pacific/Middle East/Africa (9.9%) and China/Taiwan/Hong Kong (5.6%).
Employees
8,625
Date Price Change Volume
11/11/26 USD 212.93 -0.92% 1,865,341
10/11/26 USD 214.91 -2.66% 1,363,481
09/11/26 USD 220.78 +3.59% 1,863,768
06/11/26 USD 213.13 +2.47% 2,064,505
05/11/26 USD 208.00 -8.18% 4,236,753
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Illumina, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
212.93USD
Average target price
261.45USD
Spread / Average Target
+22.79%
  1. Stock Market
  2. Stocks
  3. ILMN Stock